The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soon after vaccination, the majority of vaccinees shed polioviruses with a high frequency of such mutations (Evans et al., 1985, Stern et al., 2017), indicating that the structural stability of domV is under strong positive selection in the human gut.”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Evans et al., 1985
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
The complete nucleotide sequence of a common cold virus: human rhinovlrus 14
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7859 · Cited by 254
Self-citationStanway, G., Hughes, P. J., Mountford, R. C., Reeve, P., Minor, P. D., Schild, G. C., & Almond, J. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1539 · Cited by 188
Self-citationSome simple computational methods to improve the folding of large RNAs
Jacobson, A. B., Good, L., Simonetti, J., & Zuker, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.45 · Cited by 164
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 149
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. A., Schild, G. C., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7787 · Cited by 146
Self-citationCritical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3
Evans, D. M. A., Minor, P. D., Schild, G., & Almond, J. W. (1983) · Nature · doi:10.1038/304459a0 · Cited by 111
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citation
Research works printed but not linked: 2
- Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
- Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Cited by
Items 301–400 of 438
The long-lasting enigma of polycytidine (polyC) tract
Penza, V., Russell, S. J., & Schulze, A. J. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009739 · Cited by 12
“the discovery that a single point mutation at position 472 on domain V of the type I IRES is a major determinant of poliovirus neurovirulence and can quickly revert to wild type upon replication in the human gut, as shown by cases of vaccine-associated poliomyelitis [18].”
BackgroundThe Use of Next-Generation Sequencing for the Quality Control of Live-Attenuated Polio Vaccines
Charlton, B. G., Hockley, J., Laassri, M., Wilton, T., Crawt, L., Preston, M. D., NGS Study Group, Cassart, J.-P., Essaghir, A., Vandeputte, O. M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa299 · Cited by 12
“However, Sabin poliovirus strains in OPV are genetically unstable and have been shown to lose their attenuating mutations and revert to a neurovirulent phenotype during passage in vivo and in vitro [1, 2].”
BackgroundTranslational Control of the Picornavirus Phenotype
Agol, V. I. (2001) · Molecular Biology · doi:10.1023/a:1010531228348 · Cited by 13
Szendrôi, A., El-Sageyer, M., Takács, M., Mezey, I., & Berencsi, G. (2000) · Archives of Virology · doi:10.1007/s007050070009 · Cited by 12
“It has been demonstrated that this region has a crucial role in the viral life cycle [5, 15, 27, 38, 49, 50, 55, 57, 59, 66, 67, 70, 71] and even combined secondary structures of 5′-end and 3′-end regions might be involved [47].”
BackgroundVaccine‐associated paralytic poliomyelitis
Sullivan, A., Boyle, R. S., & Whitby, R. M. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb124660.x · Cited by 12
Epidemiology of viral encephalitis
Khetsuriani, N., & Anderson, L. J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.022 · Cited by 11
Molecular biology and the control of viral vaccines
Minor, P. D., Macadam, A. J., Cammack, N. C., Dunn, G., & Almond, J. W. (1990) · FEMS Microbiology Letters · doi:10.1016/0378-1097(90)90611-s · Cited by 11
Self-citationHumanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises
O’Connell, A. K., & Douam, F. (2020) · Vaccines · doi:10.3390/vaccines8010036 · Cited by 15
“For example, cases of vaccine-derived paralytic poliomyelitis (VAPP) and increased neurovirulence are associated with mutations in the 5' noncoding region of all three OPV strains after passage in the human gastrointestinal tract [125, 126] .”
BackgroundHovi, T. (1989) · Advances in virus research · doi:10.1016/s0065-3527(08)60837-4 · Cited by 11
Bandyopadhyay, P. K., Pritchard, A., Jensen, K., & Lipton, H. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3691-3695.1993 · Cited by 11
Hellen, C. U. T., & Wimmer, E. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch2 · Cited by 11
Kanno, T., Mackay, D., Wilsden, G., & Kitching, P. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00341-0 · Cited by 11
Toward New Viral Vaccines for Man
Norrby, E. (1987) · Advances in virus research · doi:10.1016/s0065-3527(08)60473-x · Cited by 11
M’hadheb-Gharbi, M. B., Kean, K. M., & Gharbi, J. (2007) · Molecular Biology Reports · doi:10.1007/s11033-007-9174-3 · Cited by 11
“In PV 50NTR, single nucleotide transitions within the sequence defined by nt 472–481 are likely significantly perturb RNA secondary or tertiary structures [39-41].”
BackgroundPoliovirus Studies during the Endgame of the Polio Eradication Program
Arita, M. (2016) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2016.356 · Cited by 13
“PV studies in the post-vaccine era have produced valuable tools and information essential to the eradication program, including nucleotide sequences of PV and other enteroviruses (9,10,31), which have been used to design primers for current reverse transcription (RT)-PCR systems for PV detection (32,33); neurovirulenc…”
BackgroundMethodCoulepis, A. G., Anderson, B. N., & Gust, I. D. (1987) · Advances in virus research · doi:10.1016/s0065-3527(08)60476-5 · Cited by 10
Arita, M., Shimizu, H., & Miyamura, T. (2004) · Journal of General Virology · doi:10.1099/vir.0.19768-0 · Cited by 10
“Among these attenuation determinants, a major determinant is mapped on stem–loop V (nt 448–556) of the IRES element in all Sabin strains (nt 480 in Sabin 1, nt 481 in Sabin 2 and nt 472 in Sabin 3) (Cann et al., 1984; Evans et al., 1985; Kawamura et al., 1989; Macadam et al., 1991).”
BackgroundRecombinant Polioviruses as Candidates for Oral Live Poliovaccines
Nomoto, A. (1993) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1993.tb03196.x · Cited by 10
Progress toward Vaccines against Viruses that Cause Heart Disease
Höfling, K., Kim, K., Leser, J. S., Chapman, N. M., Willian, S., Gauntt, C. J., & Tracy, S. (2000) · Herz · doi:10.1007/s000590050022 · Cited by 10
“... strains developed by Sabin et al. [24] took a great deal of time to develop and depended in the end upon the selection of randomly occurring mutations in the genome that slowed replication; even though these strains are responsible in large part for the nearly completed eradication of poliovirus worldwide, the Sab…”
BackgroundPathogenesis of Ross River virus-induced diseases: a role for viral quasispecies and persistence
Bielefeldt‐Ohmann, H., & Barclay, J. L. (1998) · Microbial Pathogenesis · doi:10.1006/mpat.1998.0203 · Cited by 10
Deficient diet evokes nasty heart virus
Gauntt, C. J., & Tracy, S. (1995) · Nature Medicine · doi:10.1038/nm0595-405 · Cited by 10
Saraswathy, T. S., Khairullah, N. S., Sinniah, M., Mk, F., Apandi, M. Y., & Shamsuddin, M. S. F. (2004) · PubMed · Cited by 10
The genomic RNA of diabetogenic encephalomyocarditis virus: characterization and molecular cloning
Jordan, G. W., Cohen, S. H., Dandekar, S., & VandenBrink, K. M. (1987) · Virology · doi:10.1016/0042-6822(87)90354-0 · Cited by 10
Cash, P. (1988) · Canadian Journal of Microbiology · doi:10.1139/m88-136 · Cited by 10
The Genome of the Group B Coxsackieviruses
Tracy, S. (1988) · Infectious agents and pathogenesis · doi:10.1007/978-1-4757-0247-7_2 · Cited by 10
Aspects of the Molecular Biology of Poliovirus Replication
Harber, J. J., & Wimmer, E. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2928-6_16 · Cited by 9
Clarke, T. (2001) · Nature · doi:10.1038/35053235 · Cited by 9
Vaccine related poliomyelitis in non-immunised relatives and household contacts.
Bateman, D. E., Elrington, G., Kennedy, P., & Saunders, M. E. (1987) · BMJ · doi:10.1136/bmj.294.6565.170 · Cited by 9
Proteins Expressed by DNA Vaccines Induce Both Local and Systemic Immune Responsesa
Whitton, J. L., & YOKOYAMA, M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52961.x · Cited by 9
Control of Pediatric Viral Diseases: Past Successes and Future Prospects
Chanock, R. M. (1990) · Pediatric Research · doi:10.1203/00006450-199006001-00011 · Cited by 8
Jarzabek, Z., Zabicka, J., John, A., Howlett, J., Dunn, G., & Wood, D. J. (1992) · Europe PMC (PubMed Central) · Cited by 8
Self-citationLevenbook, I. S., Dragunsky, E. M., & Pervikov, Y. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00190-0 · Cited by 8
Determination of poliovirus-specific IgA in saliva by ELISA tests
Ap, I., Dragunsky, E. M., Ivanova, O. E., Rezapkin, G. V., Potapova, S., & Chumakov, K. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.01.030 · Cited by 8
Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype
Phillips, L., & Tapprich, W. E. (2023) · Journal of Virology · doi:10.1128/jvi.00448-23 · Cited by 7
Deng, Y., Cai, W., Li, J., Li, Y., Yang, X., Ma, Y., Yao, Y., Yang, L., Shi, L., & Sun, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.020 · Cited by 7
Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria
Korsun, N., Kojouharova, M., Vladimirova, N., Fiore, L., Litvinenko, I., Buttinelli, G., Fiore, S., Voynova‐Georgieva, V., Mladenova, Z., & Georgieva, D. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21545 · Cited by 8
“Isolation of revertant and recombinant polioviruses from both patients with vaccine-associated paralytic poliomyelitis and healthy vaccinees suggests that host factors could play a role in development of paralysis [Evans et al., 1985; Martin et al., 2002; Martinez et al., 2004; Kew et al., 2005; Gnanashanmugam et al.,…”
BackgroundInfluentialCorrelation of mutations and recombination with growth kinetics of poliovirus vaccine strains
Pliaka, V., Kyriakopoulou, Z., Tsakogiannis, D., Ruether, I. G. A., Gartzonika, C., Levidiotou-Stefanou, S., Krikelis, A., & Markoulatos, P. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1033-9 · Cited by 10
“One substitution in the 5′-NCR of the genome and another that changes an amino acid residue in a capsid protein (VP1 in Sabin 2 and VP3 in Sabin 3) are the major determinants of attenuation and temperature sensitivity [7, 8, 15–22].”
BackgroundGenetic engineering applied to the development of vaccines
Murray, K., Stahl, S. J., & Ashton‐Rickardt, P. G. (1989) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1989.0060 · Cited by 7
Modern Approaches to Live Virus Vaccines
Norrby, E. (1989) · Advances in veterinary science and comparative medicine · doi:10.1016/b978-0-12-039233-9.50011-1 · Cited by 9
Viral sequences required for neurovirulence of poliovirus
Racaniello, V. R. (1986) · BioEssays · doi:10.1002/bies.950050608 · Cited by 9
Muscillo, M., Rosa, G. L., Carducci, A., Cantiani, L., & Marianelli, C. (1997) · Water Research · doi:10.1016/s0043-1354(97)00158-9 · Cited by 7
Eradication of Poliovirus: Fighting Fire With Fire
Nathanson, N. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq148 · Cited by 7
“The attenuated variants in the vaccine are rapidly replaced by revertant mutants, even on a single passage through the human intestine [6].”
BackgroundTon, S. H., Iskandar, K., Noriah, R., & Thanaletchimy, N. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609037957 · Cited by 7
Genomic and template RNA transcription in a model of persistent enteroviral infection
Gow, J. W., Behan, W., Cash, P., Simpson, K., & Behan, P. O. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709015796 · Cited by 7
“Enteroviruses mutate frequently and a change in a single nucleotide in the 5' nontranslated region (NTR) of the poliovirus, for instance, can cause a dramatic change in virulence (Evans et al, 1985; Pelletier et al, 1991).”
BackgroundOhara, Y., & Roos, R. P. (1989) · Annals of Neurology · doi:10.1002/ana.410250316 · Cited by 7
Wang, N., Wang, H., Shi, J., Li, C., Liu, X., Fan, J., Sun, C., Cameron, C. E., Qi, H., & Li, Y. (2021) · Viruses · doi:10.3390/v13112159 · Cited by 6
Stewart, S. R., & Semler, B. L. (1999) · Virology · doi:10.1006/viro.1999.9981 · Cited by 6
Persistence of Foot-and-Mouth Disease Virus
Salt, J. S. (2004) · CRC Press eBooks · doi:10.1201/9781420037968.ch6 · Cited by 6
Neurovirological methods and their applications
Kennedy, P. G. E. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.8.1016 · Cited by 6
Picornaviruses at the Molecular Level
Bercoff, R. P. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5350-8_8 · Cited by 8
Domingo, E., Escarmís, C., Martínez-Salas, E., Martín‐Hernández, A. M., Mateu, M. G., & Martínez, M. Á. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2928-6_19 · Cited by 5
Infectious or Acquired Motor Neuron Diseases
Moodley, M., David, W. S., & Seay, A. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00010-x · Cited by 7
Alirezaie, B., Taqavian, M., Aghaiypour, K., Esna‐Ashari, F., & Shafyi, A. (2011) · Journal of Medical Virology · doi:10.1002/jmv.21804 · Cited by 6
“…organisms (e.g., human/animal intestinal tract) [Melnick et al., 1959; MacLeod, 1966; Jarzabek et al., 1976, 1977; Kew et al., 1981, 2002, 2005; Evans et al., 1985; Hamada et al., 1988; Macadam et al., 1989; Dunn et al., 1990; Tatem et al., 1991; Contreras et al., 1992; Minor, 1992, 1999,…”
Methods to Monitor Molecular Consistency of Oral Polio Vaccine
Chumakov, K. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3292-4_14 · Cited by 5
Manukyan, H., Wahid, R., Ansari, A., Tritama, E., Macadam, A. J., Konz, J., Chumakov, K., & Laassri, M. (2022) · Vaccines · doi:10.3390/vaccines10091394 · Cited by 5
Vaccines for the Future — An Update
Ada, G. L., & Jones, P. D. (1987) · Immunology and Cell Biology · doi:10.1038/icb.1987.2 · Cited by 5
Functional Formation of Domain V of the Poliovirus Noncoding Region: Significance of Unpaired Bases
Rowe, A., Burlison, J., Macadam, A. J., & Minor, P. D. (2001) · Virology · doi:10.1006/viro.2001.1111 · Cited by 5
Self-citationPolioviruses and Mucosal Vaccines
Weeks-Levy, C., & Ogra, P. L. O. (1996) · Elsevier eBooks · doi:10.1016/b978-012410580-5/50022-4 · Cited by 5
Perspectives on Cellular Receptors as Determinants of Viral Tropism
Crowell, R. L., Landau, B. J., Hsu, K.-H. L., & Schultz, M. (1988) · Infectious agents and pathogenesis · doi:10.1007/978-1-4757-0247-7_4 · Cited by 6
The use of molecular techniques in studying viral pathogenesis in the nervous system
Kennedy, P. G. E. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90125-t · Cited by 5
Kruppenbacher, J. P., Arnold, G., Mertens, T., Fischer, A., Zimmermann, J., & Eggers, H. J. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01605460 · Cited by 5
“Even subtle changes of the picornaviral R N A may alter pathogenicity in a dramatic way, as has been shown for polioviruses (Evans et al. 1985; Eggers and Mertens 1987; Eggers 1991).”
BackgroundThe widening spectrum of infectious neurological disease.
Kennedy, P. G. E. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.8.629 · Cited by 5
Natural evolution of oral vaccine poliovirus strains
Crainic, R., Furione, M., Oţelea, D., Guillot, S., Balanant, J., Aubert-Combiescu, A., Combiescu, M., & Candrea, A. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9278-8_31 · Cited by 5
The Waterborne and Foodborne Viral Diseases Related to Reemerging of Poliovirus
Hatib, A., Hassou, N., Benchekroun, M. N., Boussettine, R., Hafid, J. E., Bessi, H., & Ennaji, M. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819400-3.00044-2 · Cited by 4
The Immunology and Pathogenesis of Persistent Virus Infections
Alp, N., & Borysiewicz, L. K. (1994) · Springer eBooks · doi:10.1007/978-94-011-1430-1_5 · Cited by 4
Variabilité génétique et virus
Fritsch, L., & Schneider, V. (1996) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(96)80182-x · Cited by 4
Polio vaccine: From empiricism and efficacyto scientific knowledge
Horaud, F., Crainic, R., & Blondel, B. (1985) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(85)80144-1 · Cited by 4
Prikazský, V., Leroux-Roels, G. G., Damme, P. V., Safary, A., Colau, B., & DUCHENE, M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.002 · Cited by 4
Enterovirus 71: Pathogenesis, Control and Models of Disease
Xin, K. W., Yeo, H., & Alonso, S. (2012) · Future Virology · doi:10.2217/fvl.12.89 · Cited by 5
Triple plaque purified strains of duck hepatitis virus and their potential as vaccines
Davis, D. A. (1987) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)30739-2 · Cited by 4
Poliovirus Neurovirulence and its Attenuation
Agol, V. I. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2928-6_21 · Cited by 4
The race for a coronavirus vaccine
Ferbeyre, G., & Vispo, N. S. (2020) · Bionatura · doi:10.21931/rb/2020.05.04.1 · Cited by 7
Poliovirus Vaccines: Past, Present, and Future
Nathanson, N., & Kew, O. M. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.77 · Cited by 4
Pöyry, T. A. A., Kinnunen, L., & Hovi, T. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800031071 · Cited by 3
Molecular Mechanisms of Poliovirus Pathogenesis
Nomoto, A., & Koike, S. (1992) · Humana Press eBooks · doi:10.1007/978-1-4612-0407-7_6 · Cited by 3
Detection of Mutants in Polio Vaccine Viruses Using Pooled Antipoliovirus Monoclonal Antibodies
Horie, H., Miyazawa, M., Ota, Y., Wakabayashi, K., Doi, T., Yoshizawa, K., Doi, Y., & Hashizume, S. (1999) · Biologicals · doi:10.1006/biol.1999.0211 · Cited by 3
Studies on the molecular aspects of antigenic structure and virulence of poliovirus
Minor, P. D., Schild, G. C., Cann, A. J., Dunn, G., Evans, D. M. A., Ferguson, M. A. J., Stanway, G., Westrop, G. D., & Almond, J. W. (1986) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(86)80198-8 · Cited by 3
Self-citationNon-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain)
Ubertini, T. R., CIONI, C., PERINI, L., & Gagnoni, S. (1988) · Vaccine · doi:10.1016/0264-410x(88)90096-5 · Cited by 3
McKnight, K. L., Sandefur, S. L., Phipps, K. M., & Heinz, B. A. (2003) · Virology · doi:10.1016/j.virol.2003.08.033 · Cited by 3
Higher Order Structures of Coxsackievirus B 5’ Nontranslated Region RNA
Currey, K. M., & Shapiro, B. A. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60687-8_8 · Cited by 3
Self-citationMolecular Studies of Viral Pathogenesis
Kennedy, P. G. E. (1992) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)01207-3 · Cited by 3
Eastman, C. G., & Tapprich, W. E. (2023) · Viruses · doi:10.3390/v15020295 · Cited by 2
Racaniello, V. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-33133-1_1 · Cited by 2
EV71 5’UTR interacts with 3D protein affecting replication through the AKT-mTOR pathway
Xu, X., Shao, M., Liu, Z., Yuan, H., Wang, Y., Chen, M., Du, M., Kan, H., Wang, Z., Chong, X., et al. (2024) · Virology Journal · doi:10.1186/s12985-024-02385-z · Cited by 2
Racaniello, V. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.004 · Cited by 2
Dommann, C. J. (1994) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1994.tb00125.x · Cited by 2
Specter, S. C., Bendinelli, M., & Friedman, H. (1992) · Infectious agents and pathogenesis · doi:10.1007/978-1-4684-5886-2_17 · Cited by 2
Jallow, S., Wilmshurst, J. M., Howard, W., Copelyn, J., Seakamela, L., Chan, K. W., Sebunya, R. K., Sibiya, R., Plessis, H. D., Jacobs, C., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz361 · Cited by 2
“Also, 3 nucleotide changes were identified in the 5′ untranslated region, including the neurovirulence-associated mutation T472C [5].”
BackgroundEstívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 4
Chapter 10 Viral infections of lower motor neurons
Solomon, T., Ooi, M. H., & Mallewa, M. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80013-3 · Cited by 2
Suppressing evolution in genetically engineered systems through repeated supplementation
Layman, N. C., Tuschhoff, B. M., Basinski, A. J., Remien, C. H., Bull, J. J., & Nuismer, S. L. (2020) · Evolutionary Applications · doi:10.1111/eva.13119 · Cited by 2
“…antigenic transgene can be completely avoided, mutations that reduce immune overlap between the vaccine and the pathogen will still be favored, reducing the effectiveness of a transmissible vaccine (Basinski et al., 2018; Bull, Smithson, & Nuismer, 2018; Evans et al., 1985; Nuismer et al., 2019).”
BackgroundCarman, W. F., & Thomas, H. C. (1990) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(90)90047-k · Cited by 2
Toward Understanding the Molecular Basis for Attenuation of Picornaviruses
Cohen, J. I. (1989) · Advances in virus research · doi:10.1016/s0065-3527(08)60584-9 · Cited by 2
Old, M. O., Logan, L. H., & Maldonado, Y. (1997) · Journal of Virological Methods · doi:10.1016/s0166-0934(97)00114-6 · Cited by 2
Lee, C., & Young, C. R. (1998) · Microbial Pathogenesis · doi:10.1006/mpat.1998.0231 · Cited by 2
Some Highlights of Animal Virus Research in 1986
McGeoch, D. J., Howard, C. R., & Desselberger, U. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-6-1501 · Cited by 2
Sutherland, S. (1988) · Journal of Hospital Infection · doi:10.1016/0195-6701(88)90205-8 · Cited by 2
The Development of New Poliovirus Vaccines Based on Molecular Cloning
Nomoto, A., Kohara, M., Kuge, S., Abe, S., Semler, B. L., Komatsu, T., Arita, M., & Itoh, H. (1988) · Springer eBooks · doi:10.1007/978-1-4757-9268-3_5 · Cited by 2
Acute disseminated encephalomyelitis associated with enterovirus 71
Omoya, K., Orii, K. E., Kondo, N., & Kato, Z. (2015) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0035-1557075 · Cited by 1
“The virulence can be determined by coat protein mutations or non-coding RNA stem loop sequences, which are well known in polioviruses, in the enterovirus [6].”
Background
Metadata
- Authors
- Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- University of Leicester (GB)
- National Institutes of Health (US)
- ORCID
- Cann, A. J.
- Venue
- Nature
- Published
- 1985-04
- Volume
- 314
- Issue
- 6011
- Pages
- 548-550
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044967254
- Cited by
- 440
- References
- 17
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 7 · 2012: 3
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-associated poliomyelitis, neurovirulence, point mutations, 5' untranslated region, genetic reversion, vaccine strain selection
- MeSH terms
- Base Sequence, DNA, Viral, Feces, Genes, Viral, Humans, Infant, Mutation, Nucleic Acid Conformation, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Structure-Activity Relationship, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.